Sato K - Search Results

1

Cellular sensitization to cis-diamminedichloroplatinum(II) by novel analogues of the protein kinase C activator lyngbyatoxin A.

Basu A, Kozikowski AP, Sato K, Lazo JS. Basu A, et al. Among authors: sato k. Cancer Res. 1991 May 15;51(10):2511-4. Cancer Res. 1991. PMID: 2021930

2

Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.

Sato K, Howell JN, Greene MH, Maher VM, McCormick JJ. Sato K, et al. Cancer Res. 1988 Sep 15;48(18):5145-50. Cancer Res. 1988. PMID: 3136916

3

Effects of confluent monolayers of density-inhibited and -transformed cells on the growth of superinoculated cells.

Sakiyama H, Terasima T, Sato K. Sakiyama H, et al. Among authors: sato k. Cancer Res. 1978 Sep;38(9):2854-8. Cancer Res. 1978. PMID: 679192 No abstract available.

4

Morphology and function of human neuroblastoma xenotransplanted in nude mice.

Hata JI, Ueyama Y, Nozi H, Tamaoki N, Akatsuka A, Shimizu K, Morikawa Y, Sato K. Hata JI, et al. Among authors: sato k. Cancer. 1984 Jun 1;53(11):2497-506. doi: 10.1002/1097-0142(19840601)53:11<2497::aid-cncr2820531123>3.0.co;2-7. Cancer. 1984. PMID: 6713347

5

The metabolism of 9-beta-d-xylofuranosyl-6-mecaptopurine in normal and neoplastic tissues.

Sato K, LePage GA, Kimball AP. Sato K, et al. Cancer Res. 1966 Apr;26(4):741-7. Cancer Res. 1966. PMID: 5934906 No abstract available.

6

METABOLIC EFFECTS OF AN ANTIBIOTIC, NSC-51954, ON SUSCEPTIBLE AND RESISTANT TUMOR CELLS.

SATO K, LEPAGE GA. SATO K, et al. Cancer Res. 1965 May;25:477-83. Cancer Res. 1965. PMID: 14297485 No abstract available.

7

TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.

Yamamoto Y, Shibata J, Yonekura K, Sato K, Hashimoto A, Aoyagi Y, Wierzba K, Yano S, Asao T, Buzdar AU, Terada T. Yamamoto Y, et al. Among authors: sato k. Clin Cancer Res. 2005 Jan 1;11(1):315-22. Clin Cancer Res. 2005. PMID: 15671561

8

A rare case of a malignant hepatic perivascular epithelioid cell tumor (PEComa) with aggressive progression following the relapse of renal pecoma despite everolimus therapy.

Kitagawa A, Nishio A, Hikita H, Kato T, Doi A, Sato K, Tahara S, Kimura Y, Ono Y, Takehara T. Kitagawa A, et al. Among authors: sato k. Clin J Gastroenterol. 2025 Jan 7. doi: 10.1007/s12328-024-02085-9. Online ahead of print. Clin J Gastroenterol. 2025. PMID: 39762618

9

Elevated p16Ink4a Expression Enhances Tau Phosphorylation in Neurons Differentiated From Human-Induced Pluripotent Stem Cells.

Holloway K, Neherin K, Song Y, Sato K, Houston A, Chen F, Ding L, Zhang H. Holloway K, et al. Among authors: sato k. Aging Cell. 2025 Jan 5:e14472. doi: 10.1111/acel.14472. Online ahead of print. Aging Cell. 2025. PMID: 39757785

10

Prognostic significance of body mass index in patients with metastatic renal cell carcinoma receiving first-line therapies.

Sato K, Takemura K, Oki R, Urasaki T, Yoneoka Y, Fujiwara R, Yasuda Y, Oguchi T, Numao N, Yamamoto S, Yonese J, Kume H, Yuasa T. Sato K, et al. Urol Oncol. 2025 Jan 4:S1078-1439(24)01045-7. doi: 10.1016/j.urolonc.2024.12.265. Online ahead of print. Urol Oncol. 2025. PMID: 39757037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,292 results

Search Page

Filters